New Zealand Passes Milestone E-cigarette Legislation

Oct.27.2022
New Zealand Passes Milestone E-cigarette Legislation
New Zealand's landmark e-cigarette legislation bans sales to under 18s and restricts use in public spaces.

On November 11, 2020, the "2020 Smokefree Environments and Regulated Products (Vaping) Amendment Act" came into effect in New Zealand. Two years later, New Zealand passed a landmark vaping legislation.


New Zealand's legislation and regulations may not be perfect, but they continue to set an example for other countries eager to combat tobacco. It's not the time to throw the baby out with the bathwater," said Nancy Lucas, co-founder of the New Zealand Vaping Advocacy Alliance.


The bill aims to ensure that smokers who want to switch to safer alternatives can use e-cigarette products and also ensure that these products are not sold or distributed to minors. It seeks to strike a balance between promoting the use of e-cigarettes for harm reduction and preventing their use among young people.


Ms. Lucas stated that while New Zealand continues to implement various industry regulations, the requirements that went into immediate effect two years ago have had a positive impact.


Starting from November 11th, 2020, the use of electronic cigarettes is prohibited in workplaces, schools, childcare centers, and other locations. Sales of electronic cigarette products to individuals under the age of 18, as well as all advertising and sponsorships related to electronic cigarette products, are also prohibited. "If youth e-cigarette use is a problem, the solution isn't changing the law, because it's already abundant. The solution lies in parental responsibility and greater enforcement by regulatory agencies. Those found selling e-cigarettes to minors may face severe penalties. Any rogue retailer now has to face the consequences, as they make good legislation look bad," Ms. Lucas said.


The New Zealand E-Cigarette Advocacy Group has stated that the title of the Ministry of Health's website on e-cigarettes being "less harmful than smoking" is also world-leading.


New Zealand is currently engaged in a public battle to achieve a smoke-free status by 2025, which would mean reducing smoking rates to 5% or below. In comparison, Australia's ban on selling safer nicotine products and scaremongering tactics with publicly-funded campaigns have had little impact in reducing smoking rates in recent years, according to a spokesperson. In order to further curb the appeal and availability of deadly tobacco, the Health Select Committee will deliver a report on amendments to create smoke-free environments and regulated products, including traditional tobacco, by December 1st.


Ms. Lucas stated that now is the time for a strict crackdown on tobacco, rather than re-prosecuting the electronic cigarette rules and regulations that were fiercely debated and scrutinized by parliament and health leaders. "Governments, politicians, and officials from around the world continue to study the work that New Zealand has done in reducing smoking rates and achieving a smoke-free goal. Maintaining its harm reduction approach to tobacco is how New Zealand will suppress tobacco and save thousands of lives each year," said Nancy Lucas.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's contents. The compilation of this article is intended solely for industry exchange and research.


Due to limitations in translation proficiency, the translated article may not fully express the content of the original piece. Please refer to the original article for accuracy.


2FIRSTS is in complete alignment with the Chinese government when it comes to any domestic, Hong Kong, Macau and Taiwan-related, or foreign positions and expressions.


The copyright of the compiled information belongs to the original media and author. If there is infringement, please contact us to request removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives